Novelix Pharma.

{
  "main_header": {
    "sid": 200695,
    "name": "Novelix Pharma.",
    "stock_name": "Novelix Pharma.",
    "full_name": "Novelix Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/novelix-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "79.48",
    "chg": 3.34,
    "chgp": "4.39%",
    "dir": 1,
    "prev_price": "76.14",
    "mcapval": "182.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 536565,
    "symbol": "",
    "ind_name": "Retailing",
    "ind_code": 4,
    "sector_id": 72,
    "indexname": "India SENSEX",
    "isin": "INE314I01036",
    "curr_date": "Jun 11, 03:30 PM",
    "curr_time": "00:15 AM",
    "last_traded_at": "Jun 11, 03:30 PM IST",
    "bse_nse_vol": "38.89 k",
    "exc_status": "Active",
    "traded_date": "Jun 11, 2026",
    "traded_date_str": "2026 06 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novelix-pharma-200695-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Novelix Pharmaceuticals Ltd to 52-Week High of Rs 78.94",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-hits-new-52-week-high-at-rs7894-4041088",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_priceRelatedfactors_4041088.png",
        "date": "2026-06-09 10:40:41",
        "description": "With a remarkable 48.09% gain over the past five trading sessions, Novelix Pharmaceuticals Ltd surged to a fresh 52-week high of Rs 78.94 on 09 Jun 2026, showcasing robust momentum driven by a confluence of bullish technical indicators."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Novelix Pharmaceuticals Ltd Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-stock-hits-all-time-high-on-9-june-2026-4041006",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_priceRelatedfactors_4041006.png",
        "date": "2026-06-09 10:21:01",
        "description": ""
      },
      {
        "title": "Broad-Based Technical Strength Lifts Novelix Pharmaceuticals Ltd to 52-Week High of Rs 71",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-hits-new-52-week-high-at-rs71-4037620",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_priceRelatedfactors_4037620.png",
        "date": "2026-06-08 09:42:50",
        "description": "Surging to an intraday peak of Rs 71 on 8 Jun 2026, Novelix Pharmaceuticals Ltd has marked a significant milestone by hitting a fresh 52-week high. This breakout comes amid a sustained four-day rally that has propelled the stock up by 32.9%, underscoring robust price momentum despite a broadly subdued market backdrop."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-valuation-shift-signals-price-attractiveness-change-4036674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_valuationdot_4036674.png",
        "date": "2026-06-08 08:00:12",
        "description": "Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting a significant change in price attractiveness. This article analyses the recent valuation metrics, compares them with peer averages and historical benchmarks, and assesses the implications for investors amid the company’s strong market performance."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4029035",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_valuationdot_4029035.png",
        "date": "2026-06-02 08:00:38",
        "description": "Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, reflecting a more attractive price point for investors. This change comes amid a mixed performance backdrop and evolving market dynamics within the retailing sector."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4026280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_mojoScore_4026280.png",
        "date": "2026-06-01 10:10:04",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "When is the next results date for Novelix Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-novelix-pharmaceuticals-ltd-4015367",
        "imagepath": "",
        "date": "2026-05-26 23:21:42",
        "description": "The next results date for Novelix Pharmaceuticals Ltd is scheduled for 29 May 2026...."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4002904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovelixPharmace_mojoScore_4002904.png",
        "date": "2026-05-21 10:10:05",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-3984138",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovelixPharmace_mojoScore_3984138.png",
        "date": "2026-05-10 10:10:02",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 126,
    "sid": "200695",
    "stock_news_url": "https://www.marketsmojo.com/news/novelix-pharmaceuticals-200695"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "10-Jun-2026",
      "details": "Newspaper Publication EGM Notice.",
      "source": "BSE"
    },
    {
      "caption": "Shareholders Meeting- Notice Of Extra-Ordinary General Meeting Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.",
      "datetime": "09-Jun-2026",
      "details": "Notice of Extra Ordinary General Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Preferential Issue",
      "datetime": "05-Jun-2026",
      "details": "Submission of Intimation of Preferential Issue.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has declared <strong>3%</strong> dividend, ex-date: 16 Aug 12",
          "dt": "2012-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has announced <strong>10:1</strong> stock split, ex-date: 04 Oct 10",
          "dt": "2010-10-04",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Novelix Pharmaceuticals Ltd to 52-Week High of Rs 78.94

2026-06-09 10:40:41

With a remarkable 48.09% gain over the past five trading sessions, Novelix Pharmaceuticals Ltd surged to a fresh 52-week high of Rs 78.94 on 09 Jun 2026, showcasing robust momentum driven by a confluence of bullish technical indicators.

Read full news article

Strong Momentum Meets Stretched Valuations as Novelix Pharmaceuticals Ltd Reaches All-Time High

2026-06-09 10:21:01

Read full news article

Broad-Based Technical Strength Lifts Novelix Pharmaceuticals Ltd to 52-Week High of Rs 71

2026-06-08 09:42:50

Surging to an intraday peak of Rs 71 on 8 Jun 2026, Novelix Pharmaceuticals Ltd has marked a significant milestone by hitting a fresh 52-week high. This breakout comes amid a sustained four-day rally that has propelled the stock up by 32.9%, underscoring robust price momentum despite a broadly subdued market backdrop.

Read full news article

Novelix Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change

2026-06-08 08:00:12

Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting a significant change in price attractiveness. This article analyses the recent valuation metrics, compares them with peer averages and historical benchmarks, and assesses the implications for investors amid the company’s strong market performance.

Read full news article

Novelix Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-06-02 08:00:38

Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, reflecting a more attractive price point for investors. This change comes amid a mixed performance backdrop and evolving market dynamics within the retailing sector.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold by MarketsMOJO

2026-06-01 10:10:04

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

When is the next results date for Novelix Pharmaceuticals Ltd?

2026-05-26 23:21:42

The next results date for Novelix Pharmaceuticals Ltd is scheduled for 29 May 2026....

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-05-21 10:10:05

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-05-10 10:10:02

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

View All News